138 related articles for article (PubMed ID: 12457442)
1. Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity.
D'Cruz OJ; Uckun FM
Expert Opin Investig Drugs; 2002 Dec; 11(12):1829-36. PubMed ID: 12457442
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]).
Narla RK; Chen CL; Dong Y; Uckun FM
Clin Cancer Res; 2001 Jul; 7(7):2124-33. PubMed ID: 11448932
[TBL] [Abstract][Full Text] [Related]
3. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity.
Narla RK; Dong Y; Klis D; Uckun FM
Clin Cancer Res; 2001 Apr; 7(4):1094-101. PubMed ID: 11309362
[TBL] [Abstract][Full Text] [Related]
4. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, X-ray structure, and anti-leukemic activity of oxovanadium(IV) complexes.
Dong Y; Narla RK; Sudbeck E; Uckun FM
J Inorg Biochem; 2000 Mar; 78(4):321-30. PubMed ID: 10857913
[TBL] [Abstract][Full Text] [Related]
6. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
7. Metvan, bis(4,7-Dimethyl-1,10-phenanthroline)sulfatooxidovanadium(IV): DFT and Spectroscopic Study-Antitumor Action on Human Bone and Colorectal Cancer Cell Lines.
León IE; Ruiz MC; Franca CA; Parajón-Costa BS; Baran EJ
Biol Trace Elem Res; 2019 Sep; 191(1):81-87. PubMed ID: 30519799
[TBL] [Abstract][Full Text] [Related]
8. Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
Sanna D; Ugone V; Micera G; Buglyó P; Bíró L; Garribba E
Dalton Trans; 2017 Jul; 46(28):8950-8967. PubMed ID: 28640312
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
D'Cruz OJ; Dong Y; Uckun FM
Anticancer Drugs; 2000 Nov; 11(10):849-58. PubMed ID: 11142693
[TBL] [Abstract][Full Text] [Related]
10. An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage.
Basu A; Bhattacharjee A; Samanta A; Bhattacharya S
Drug Chem Toxicol; 2017 Jul; 40(3):359-367. PubMed ID: 27868436
[TBL] [Abstract][Full Text] [Related]
11. Bis(4,7-dimethyl and 5-dinitro-1,10-phenanthroline) sulfato-oxovanadium(IV)-mediated in vivo male germ cell apoptosis.
D'Cruz OJ; Uckun FM
J Appl Toxicol; 2001; 21(4):331-9. PubMed ID: 11481668
[TBL] [Abstract][Full Text] [Related]
12. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis inducing novel anti-leukemic agent, bis(4,7-dimethyl-1,10 phenanthroline) sulfatooxovanadium(IV) [VO(SO4)(Me2-Phen)2] depolarizes mitochondrial membranes.
Narla RK; Dong Y; Uckun FM
Leuk Lymphoma; 2001 May; 41(5-6):625-34. PubMed ID: 11378580
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
[TBL] [Abstract][Full Text] [Related]
15. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy.
Hassan HT
Leuk Res; 2004 Jul; 28(7):667-71. PubMed ID: 15158086
[TBL] [Abstract][Full Text] [Related]
16. [Anticancer activity of oxovanadium compounds].
Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).
Heffeter P; Jakupec MA; Körner W; Wild S; von Keyserlingk NG; Elbling L; Zorbas H; Korynevska A; Knasmüller S; Sutterlüty H; Micksche M; Keppler BK; Berger W
Biochem Pharmacol; 2006 Feb; 71(4):426-40. PubMed ID: 16343446
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells.
De Vizcaya-Ruiz A; Rivero-Muller A; Ruiz-Ramirez L; Kass GE; Kelland LR; Orr RM; Dobrota M
Toxicol In Vitro; 2000 Feb; 14(1):1-5. PubMed ID: 10699355
[TBL] [Abstract][Full Text] [Related]
20. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]